Theranexus
Developing drug combinations that consist of one compound that targets neurons and another that modulates the activity of astrocytes.
Launch date
Employees
Market cap
AUD7.9m
Enterprise valuation
AUD6m (Public information from Sep 2024)
Share price
€0.6 ALTHX.PA
Company register number 791889777
Lyon Auvergne-Rhône-Alpes (HQ)
Authorizing premium user...